HCSG NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Healthcare Services Group Inc · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 23.30 USD
2.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 10.3% above the Trend Line and sits at 80.7% of its 52-week range. The latest completed week returned 2.5%, after a -7.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 48/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 81d.

Setup score 59 out of 100
Latest Close 23.30 USD 31 Jul 2026
1W Return 2.5% latest completed week
4W Return -7.4% short-term follow-through
12W Return 1.0% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 65-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.5% Latest completed week; four-week move -7.4%. Indicator stack 100/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 48/100 conviction; expected move 8.4%. News sentiment 54/100 87 relevant articles in the latest sentiment read. Event risk 81d Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.3% above the Trend Line and sits at 80.7% of its 52-week range. The latest completed week returned 2.5%, after a -7.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8212-week average 0.67

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.4% over four weeks, 1.0% over 12 weeks, and 78.3% over one year. The current trend has remained active for 65 consecutive weeks.

Performance by holding period

1W2.5%
4W-7.4%
12W1.0%
26W23.8%
52W78.3%
Active trend streak65 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.74Latest activity-pressure read.
Pressure change-23.2%Four-week change in activity pressure.
Leadership10.60Latest relative-leadership reading.
RS change-42.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength97/100Blend of value, momentum, and quality. Underlying universe rank 4; rank 1 is best.
Value84/100Relative valuation strength. Underlying universe rank 17; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum92/100Medium-term price momentum. Underlying universe rank 9; rank 1 is best.
Growth14/100Revenue and earnings growth. Underlying universe rank 87; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework85/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.7x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
9.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.3%
Gross profit retained from each unit of revenue.
Operating margin
7.7%
Operating profit retained from revenue.
Free-cash-flow margin
8.7%
Free cash flow generated from revenue.
Return on invested capital
28.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
58.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
3.9%
Net share repurchases relative to market value.
Shareholder yield
3.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HCSG shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 0.22, expected move of 8.4%, and Sharemaestro trend signal active.

Conviction48/100
Expected move8.4%
Put/call volume0.22
Pressure74
Speculation11
Volatility89
Trend agreement21
Open options detail
Insider activity14 / 3

14 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 87 relevant articles.

23 positive · 60 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings81dNext report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
Options expected move8.4%Nearest-chain priced movement where available.
52-week drawdown-9.5%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+17.0%Week of 24 Apr.
Worst week-10.2%Week of 24 Jul.
Latest week+2.5%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses6
Sharp losses7
Recent vol6.0%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

 Indicator analysis68/100

Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 9/12.

Activity pressure 0.82; 5 reversal markers Factors88/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 15; Small Cap Core rank 23 SVQF85/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 112.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

HCSG shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 0.22, expected move of 8.4%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 8.4% Sentiment54/100

Weighted news tone is neutral across 87 relevant articles.

Healthcare Services Group (Nasdaq: HCSG) returns to profit in 2026 Insiders14 / 3

14 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings81d

Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202623.30 USD2.5%21.12 USD14.05 USD0.7410.603.7MOn
24 Jul 202622.74 USD-10.2%20.92 USD13.98 USD0.969.235.4MOn
17 Jul 202625.31 USD6.4%20.82 USD13.92 USD1.1620.383.0MOn
10 Jul 202623.79 USD-5.4%20.62 USD13.85 USD1.109.393.0MOn
3 Jul 202625.15 USD3.5%20.48 USD13.79 USD0.9718.372.4MOn
26 Jun 202624.31 USD6.0%20.27 USD13.72 USD0.5716.005.3MOn
19 Jun 202622.94 USD2.5%20.08 USD13.66 USD0.115.023.6MOn
12 Jun 202622.38 USD9.8%19.92 USD13.61 USD-0.245.422.9MOn
5 Jun 202620.37 USD-1.1%19.75 USD13.56 USD-0.37-1.613.3MOn
29 May 202620.60 USD0.8%19.65 USD13.52 USD-0.11-4.892.9MOn
22 May 202620.43 USD-3.9%19.55 USD13.47 USD-0.02-2.902.7MOn
15 May 202621.25 USD-7.8%19.49 USD13.43 USD0.302.262.4MOn
8 May 202623.06 USD8.3%19.33 USD13.39 USD0.0710.723.0MOn
1 May 202621.30 USD-5.0%19.06 USD13.34 USD-0.208.113.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.